Returning guest, Dr. Keyan Salari, a urologic oncologist and surgeon, Co-Director, Prostate Cancer Genetics Program at Massachusetts General Hospital discusses his study “Impact of Family History and Germline Genetic Risk Variants on Long-Term Outcomes of Active Surveillance-Eligible Prostate Cancer” that was presented at AUA 2022. 

Keyan Salari, MD, PhD is a urologic oncologist at the Massachusetts General Hospital and Harvard Medical School. He is a urologic surgeon specialized in the treatment of genitourinary cancers using open, laparoscopic, and robotic surgery techniques. His research focuses on applying cancer genomics and computational biology methods to advance precision cancer medicine for genitourinary malignancies.

Liked it? Take a second to support healthprofessionalradio on Patreon!